N-Arylimidazoliums As Highly Selective Biomimetic Antimicrobial Agents

Qunshou Kong,Gaocan Li,Fanjun Zhang,Tao Yu,Xiaotong Chen,Qing Jiang,Yunbing Wang
DOI: https://doi.org/10.1021/acs.jmedchem.2c00818
IF: 8.039
2022-01-01
Journal of Medicinal Chemistry
Abstract:Antibiotic resistance has become one of the greatest health threats in the world. In this study, a charge-dispersed dimerization strategy is described for the antimicrobial peptide (AMP) mimics via a tunable cationic charge to improve the selectivity between prokaryotic microbes and eukaryotic cells. This strategy is demonstrated with a series of charge-dispersed AMP mimics based on N-arylimidazolium skeletons. These N-arylimidazolium AMP mimics show potent antibacterial activity against strains along with a low rate of drug resistance, good hemocompatibility, and low cytotoxicity. In addition to the elimination of planktonic bacteria, N-arylimidazolium AMP mimics can also inhibit biofilm formation and destroy the established biofilm. More importantly, methicillin-resistant Staphylococcus aureus (MRSA)-induced lung-infected mice can be effectively treated by the intravenous administration of N-arylimidazolium AMP mimic, which enable the design of N-arylimidazolium AMP mimics to offer an alternative avenue to eradicate drug-resistant bacterial infection.
What problem does this paper attempt to address?